Manjunath and Nidhi Mathur , NIRAMAI has so far raised a total of US $ 14 million from institutional investors from India , Japan and Singapore . Investors include Dream Incubator , BeeNext , pi Ventures , Ankur Capital , Axilor Ventures , 500 Startups , and Flipkart co-founder Binny Bansal .
NIRAMAI has now created its own reputed brand in India with their innovative breast health products . Partnering with experienced radiologists , reputed hospital AND diagnostic chains in India such as Apollo Clinics , HCG Cancer Hospitals , Rainbow Hospitals among others , it provides breast screening services across 19 cities in India . With the FDA cleared SMILE-100 System and CE approved Thermalytix™ products , the company is now taking their Made-in- India innovation to global scale .
Key Milestones
NIRAMAI has won some prestigious awards including Global Women ’ s HealthTech Award by World Bank and IFC in 2022 , National Startup Award 2020 in India and the Gold prize in Hack Osaka 2019 in Japan and was the winner of BNP Paribas Call4Ideas in Italy . They were also the winners of Accenture AI award , Aegis GrahamBell Award , Amazon AI Award and are part of the NVidia Inception program . NIRAMAI was also accelerated at Google launchpad in San Francisco and have received research funding from the Bill & Melinda Gates
Foundation and CDC UK .
In 2021 , NIRAMAI received the prestigious CE Mark Approval , ISO 13485 and MDSAP ( Medical Device Single Audit Program ) International Certifications enabling it to sell the product freely in any part of the European Economic Area . These certifications endorse medical device manufacturers for their compliance with the international medical device quality standards and regulatory requirements .
In October 2023 , Molbio Diagnostics , a pioneering in-vitro diagnostics ( IVD ) unicorn launched a strong collaboration with NIRAMAI to accelerate the adoption of latter ’ s innovative AI-based non-invasive breast cancer screening solution , Thermalytix ® in developing countries around the world .
BIOVOICENEWS . COM 23